COVID 19 Impact on Indonesia Clinical Lab Market: Ken Research REQUEST FOR SAMPLE REPORT Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Buy Now How The Indonesia Clinical Lab Market Is Positioned? Indonesia Clinical Lab market was observed to grow with an augmenting growth rate in the review period 2016-2021. The Indonesia Clinical Lab market in terms of Revenue has increased at a positive CAGR of ~% during the review period 2016-2021. The growth was supported by increase in healthcare spending by aging population, expanding health insurance, growth in non-communicable disease and chronic diseases, rising disposable Income. The market for clinical labs in Indonesia is highly fragmented among the top players. While talking in terms of region, Greater Jakarta and Java, Bali and Nusa contribute more than half of the revenue share. There are about ~ organized players in the market who also dominate the overall market in terms of revenue. The market is dominated by public hospital labs. The overall focus accreditation is low in the market especially in the unorganized sector. Around 70% of medical decisions regarding early disease diagnosis, patient prognosis and treatment selection are based on laboratory diagnostic results. Along with treatment regime selection, diagnostic test results help in monitoring of the patient condition during recovery and follow-up. With these multiple touchpoints, laboratory tests contribute 80% of the objective data in clinical records. In modern medicine, with data analytics and AI taking center stage, these clinical records will help in predictive analysis and disease prevention going forward. Indonesia Clinical Lab Market Segmentation By Type of Labs: Clinical Laboratories can be recognized as Independent Labs, Private Hospital Labs and Public Hospital Labs. Public Hospital Labs have a majority in the Indonesian market followed by Private Hospital Labs. By Number of Labs: The labs can be recognized as public or private labs basis their ownership. Private Labs dominate the market in Indonesia. Click Here for Sample Report: – https://www.kenresearch.com/sample-report.php?Frmdetails=NTI0MDQ5 By Type of Private Independent Labs: Basis this segmentation, laboratories can be recognized as organized and unorganized labs. Organized labs being those which have more than 3 branches in the region versus unorganized labs who have 3 or less than 3 labs in the region. In Indonesia, organized labs dominate the market with a market share of ~% followed by unorganized labs with a share of ~%. By Type of Payor: Corporates have accounted for the largest share of ~% of the number of tests in Indonesia. As the growing Indonesian workforce has led to an increase in corporate clients for pre-employment checks and annual health checks. More companies are engaging with private medical labs. By Type of Consumer (Basis Number of Tests): Majority of the patients who are consumer to these laboratories come through doctor referrals with a market share of ~% based on the number of tests. This is followed by walk-ins and corporate clients with a market share of ~% and ~% respectively. By Type of Tests: On the basis of type of tests the market is split between Routine, Esoteric and Non-laboratory tests. The most popular in the market are Routine tests with a market share of ~%. The non-laboratory tests account for a relatively small share of lab tests due to the additional licenses required to carry them out. Thus, laboratories are reluctant to do those tests. By Type of Routine Tests: The routine tests have different categories of tests. The leader in this category is CBC followed by Basic Metabolic Panel. By Esoteric tests: The esoteric tests have different categories of tests. The leader in this category is endocrine followed by infectious disease. By Region: Java, Jakarta and Bali have high rate of urbanization and more affluent population, which has created greater access and demand for private clinical laboratory testing services. By Private Hospital Labs: Private hospitals either have their own in-house labs or have a tie-up with a third-party lab to accommodate their labs. In Indonesia in-house laboratories have a greater share. What is the competition scenario in the Indonesia clinical lab market? Market is dominated by Prodia (PRDA), contributing more than ~% of the market share by revenue with ¬ outlets across 127 cities and 34 provinces in Indonesia which makes PRDA as a market leader. Kimia farma is the 2nd major player with ¬% market share and Bio medika is the least contributor i.e., ¬%. CITO contributed ¬% of market share and was designated by the Ministry of Health to be one of the laboratories for examining the coronavirus. This helped to be recognized across the region and thereby sustain footprints in the market. To capture the shift, industry leaders have started to implement initiatives such as retailer partnering, offering home testing, and enhancing engagement with patients through digital presence. Company Profile Of Major Players Operating In Indonesia Clinical Lab Market (Case Study) Prodia: PRDA applies the hub and spoke business model, which currently has 4 hubs in Jakarta, Medan, Surabaya and Makassar, while the number of spokes owned is around 148 branches. Spokes/branches carry out 300-400 types of routine tests, while at the hubs, they carry out 800-850 types of tests, both routine & esoteric tests. Diagnos: The Company realizes that currently it is still very necessary to deploy a Laboratory Network, both as a health facility in a hospital, independent branches and outlets Indonesia Clinical Lab Market Future Outlook and Projections Over the forecast period 2022-2026F, the Indonesia Clinical Lab Market Revenue is further anticipated to increase to USD ~ Million by the year 2026F, thus showcasing a CAGR of ~%. It is expected that the implementation of JKN will increase the demand for laboratory services. This will lead the public hospitals to refer samples to private independent laboratories for clinical testing, resulting in the growth of external referrals for private independent laboratories. Players, investing to increase its testing capabilities and has adopted several advanced tests and technologies introduced in the global market, particularly specialized tests. Further, the major private independent laboratories chains are expected to undergo geographic expansion beyond key cities into underdeveloped areas. This will further lead to increase in market share in the overall Indonesia clinical laboratory market. For More Information on the Research Report, refer to below links: – Indonesia Clinical Laboratory Market Related Reports by Ken Research: – Vietnam Clinical Laboratory Market Outlook to 2022 – by Labs (Hospital Labs, Independent Labs and Physician Office Labs) and Type of Tests (Lab Test, X-Ray, Ultrasound and CT Scan) Indonesia Clinical Laboratory Market Outlook to 2022 – By Type (Public Clinical Lab, Private Hospital Labs and Private Independent Labs), By Type of Test (Routine, Non Laboratory and Esoteric) Contact Us: – Ken Research Ankur Gupta, Head Marketing & Communications support@kenresearch.com +91-9015378249 Follow Us LinkedIn | Instagram | Facebook | Twitter | YouTube Tags: Central Java Esoteric Tests Market Share, Clinical Laboratory companies in Kalimantran, Clinical Laboratory Industry in Indonesia, Clinical Laboratory Market in Indonesia, Covid-19 Impact Indonesia Clinical Laboratory Market, Health Infrastructure Gaps in Indonesia, Health Infrastructure in Indonesia, Healthcare Market in Indonesia, In-HouseThird Party Clinical Labs in Greater Jakarta, Independent Clinical Labs in Central Sumatera, Indonesia Clinical Lab Industry Indonesia Clinical Laboratory Market Research Report, Indonesia Clinical Lab Market, Indonesia Clinical Laboratory Industry, Indonesia Clinical Laboratory Industry Research Report, Indonesia Clinical Laboratory Market, Indonesia Clinical Laboratory Market Analysis, Indonesia Clinical Laboratory Market Forecast, Indonesia Clinical Laboratory Market Future Outlook, Indonesia Clinical Laboratory Market Growth Rate, Indonesia Clinical Laboratory Market Major Players, Indonesia Clinical Laboratory Market Revenue, Indonesia Clinical Laboratory Market Share, Indonesia Clinical Laboratory Market Size, Indonesia Healthcare Market, Indonesia Organized Clinical Labs Market, Indonesia Unorganized Clinical Labs Market, Number of Clinical Labs in indonesia, Number of Private Hospital Labs in Indonesia, Organised Clinical Laboratories in Sulawesi, Pathlab Indonesia Market Growth Rate, Prima Medika Indonesia Non-Laboratory Tests Market, Report on Indonesia Clinical Laboratory Market, Ultra Medica lab Market Share in Indonesia